Emory University
The Take Home: ACC
The American College of Cardiology Scientific Session produced some groundbreaking findings with major implications for the practice of interventional cardiology. Most stunning was two trials that showed transcatheter aortic valve replacement bested surgery in low-risk patients with severe aortic stenosis; reaction to those data appears in the Cover Story.
Lenalidomide delays progression of smoldering myeloma
Recent insurance policy changes for depression tied to increased treatment
VIDEO: Novel combinations can capitalize on immunogenicity of head and neck cancer
NEW YORK — Nabil F. Saba, MD, FACP, professor of hematology/medical oncology and otolaryngology and director of the head and neck oncology program at Winship Cancer Institute at Emory University, spoke at HemOnc Today New York about combination approaches for head and neck squamous cell carcinoma in the immunotherapy era.
Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer
FDA grants breakthrough therapy designation for ticagrelor reversal agent
Osimertinib plus intermittent selumetinib shows preliminary activity in EGFR-mutated lung cancer
ATLANTA — Osimertinib plus intermittent selumetinib demonstrated preliminary antitumor activity and acceptable toxicity in patients with EGFR-mutated non-small cell lung cancer whose disease progressed during prior treatment with an EGFR tyrosine kinase inhibitor, according to results of the phase 1b TATTON study presented at American Association for Cancer Research Annual Meeting.